top of page
  • Angela Tufvesson - Hong Kong

Editor's letter

Dear readers and health advocates,

Cardiovascular disease is the leading cause of global mortality, accounting for a staggering 32% of all deaths. More than three-quarter of the deaths from cardiovascular disease takes place in low- and middle-income countries. Across the world, health systems are overburdened, and the inequity in healthcare access persists.

In time for World Heart Day on 29 September and throughout the autumn, our special report investigates what is holding us back from improving cardiovascular health outcomes and explores innovative solutions propelling us towards a brighter, heart healthier future.

We probe the latest research and speak to internationally renowned experts about the viability of the polypill—a combination of heart and hypertension medications—as a primary or secondary prevention tool. A landmark study found that when taken after a heart attack, the polypill prevents further heart problems when compared to taking each medication separately. Will these findings give the polypill wider acceptance?

With stroke a growing problem in low- and middle-income countries, we examine the ways in which countries can prevent strokes and improve awareness of symptoms, as well as share case studies of best practice.

As the Indian government invests in health and wellness centres, we look at how the country is working to make cardiovascular care more accessible to women—who, contrary to popular belief, are just as susceptible to the condition as men.

In our popular ‘1 question, 5 answers’ series, we speak to five eminent experts from diverse international backgrounds about the fascinating and important link between influenza vaccination and cardiovascular health.

We look forward to continuing working together to improve cardiovascular health outcomes across the world.

Angela Tufvesson


bottom of page